DCT

2:09-cv-06383

Merck Sharp & Dohme Corp v. Mylan Pharma Inc

General

Filed

12/16/09

Cause of ActionInfringement

SectorBiotech

Status

Closed (12/04/12)

Patent Owner

Operating Company (W)

PACER2:09-cv-06383

Appeals12-1434

CourtD. New Jersey

Judge	Period	PO Win Rate
Jose L. Linares	--	80%

Plaintiff

Party

Name	Ratings
Merck Sharp & Dohme Corp	L5A
Schering Corp	L5A
MSD Intl GmbH	L5A
Merck Sharp & Dohme LLC	L5A
MSP Singapore Co LLC	L1B

Attorney

Name	Ratings
Sidley Austin LLP	L5A
Todd L. Krause	L5A
David T. Pritikin	L4A
William H. Baumgartner, Jr.	L4A
Peter S. Choi	L4B
James Suh	L2C
Lowenstein SandlerLocal	L2A
Douglas S. Eakeley	L2A
Jason E. Halper	L1A
Cristina Baragona	---- --
Cristina Finetti	---- --
Robinson MillerLocal	L1A
Donald A. Robinson	L1A
Attorney at LawLocal	---- --
David M. Goldstein	---- --
Ross C. Paolino	---- --

Defendant

Party

Name	Ratings
Mylan Pharmaceuticals Inc	L5E
Mylan Inc	L5E
Mylan NV	L5E
Teva Pharmaceuticals USA Inc	L5E
Teva Pharmaceutical Industries Ltd	L5E

Attorney

Name	Ratings
Alston & Bird LLP	L5A
John W. Cox	L4B
Blas P. Arroyo	L4C
Thomas J. Parker	L4D
Deepro Mukerjee	L4D
Natalie C. Clayton	L3D
Srilakshmi M. Ravi	L3D
Jitendra Malik	L2B
Matthew J. McNeill	---- --
Rodney J. Ganske	---- --
Michael P. Kenny	---- --
Adam J. Biegel	---- --
SaiberLocal	L3E
Arnold B. Calmann	L4E
Jeffrey S. Soos	L3E
Jakob B. Halpern	L1B
Rita D. Turner	L1C
Patunas TarantinoLocal	L2E
Michael E. Patunas	L3E